Niederer Kraft Frey (NKF) advised Medermis Clinics on its partnership with Mediplaza, operating Uster-based Plaza Kliniken. The parties Headquartered in Munich, Medermis Clinics specialises across a plethora of medical areas, including dermatology, phlebology, laser medicine,
Baker McKenzie advised Zug Estates Holding on the placement of an additional CHF 100 million fixed-interest green bond in the Swiss market. The bond carries a coupon of 1.25% and will mature in seven years time. The
Niederer Kraft Frey (NKF) advised Sygnum in connection with the company’s offering of a tokenized investment instrument, with a collateralized BTC-backed loan serving as underlying asset. The instrument in question is part of the
MLL Legal advised Previse Systems on its recent growth investment round. In connection with the deal, the company secured growth capital from global growth equity platform Lightrock. Headquartered in Zug, Previse Systems is an ETRM
Walder Wyss advised dsm-firmenich on the sale of Pentapharm and its Brazilian sister company Pentapharm do Brasil Comércio e Exportação to Orlando Capital V. Founded in 1948 and headquartered in Aesch, Pentapharm is a
Walder Wyss advised the Dec Group – a specialist in high-containment processing technologies for the pharmaceutical, chemical, and specialty industries – and its existing shareholders, throughout completion of a financial partnership with ICG, an alternative asset manager
Pestalozzi advised the shareholders of Swiss consulting firm abaQon in connection with company’s integration into the Eraneos Group – the latter being represented by Walder Wyss. The parties Headquartered in Zug, abaQon specialises in strategic
Vischer advised Loomis in connection with its acquisition of Kipfer Logistik, a Swiss logistics company specialising in temperature-controlled transport and storage for the pharmaceutical sector. The Vischer team Partner Benedict F. Christ (corporate/M&
Abacus Medicine Group – a Danish group active across the modern healthcare sector – completed the acquisition of Swiss Cardio Technologies. In connection the deal Shellenberg Wittmer advised the buyer, while Baker McKenzie Switzerland represented the shareholders
Walder Wyss advised Evulpo, a Swiss EdTech start-up, throughout completion of a CHF 8.8 million Series A financing round. The investors The round saw participation from new and existing investors, including Serpentine Ventures, as well as
